141 related articles for article (PubMed ID: 23995094)
1. High antitumor activity of 5,7-dihalo-8-quinolinolato cerium complexes.
Chen ZF; Wei JH; Liu YC; Liu M; Gu YQ; Huang KB; Wang M; Liang H
Eur J Med Chem; 2013 Oct; 68():454-62. PubMed ID: 23995094
[TBL] [Abstract][Full Text] [Related]
2. The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline.
Liu YC; Wei JH; Chen ZF; Liu M; Gu YQ; Huang KB; Li ZQ; Liang H
Eur J Med Chem; 2013 Nov; 69():554-63. PubMed ID: 24095749
[TBL] [Abstract][Full Text] [Related]
3. High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes.
Chen ZF; Peng Y; Gu YQ; Liu YC; Liu M; Huang KB; Hu K; Liang H
Eur J Med Chem; 2013 Apr; 62():51-8. PubMed ID: 23353732
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dichloro-8-quinolinolato-lanthanides.
Chen ZF; Gu YQ; Song XY; Liu YC; Peng Y; Liang H
Eur J Med Chem; 2013 Jan; 59():194-202. PubMed ID: 23220648
[TBL] [Abstract][Full Text] [Related]
5. High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides.
Chen ZF; Song XY; Peng Y; Hong X; Liu YC; Liang H
Dalton Trans; 2011 Feb; 40(8):1684-92. PubMed ID: 21258737
[TBL] [Abstract][Full Text] [Related]
6. Complexes of lanthanides(iii) with mixed 2,2'-bipyridyl and 5,7-dibromo-8-quinolinoline chelating ligands as a new class of promising anti-cancer agents.
Qin QP; Wang ZF; Tan MX; Huang XL; Zou HH; Zou BQ; Shi BB; Zhang SH
Metallomics; 2019 May; 11(5):1005-1015. PubMed ID: 31045193
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.
Qin QP; Wang SL; Tan MX; Liu YC; Meng T; Zou BQ; Liang H
Eur J Med Chem; 2019 Jan; 161():334-342. PubMed ID: 30384040
[TBL] [Abstract][Full Text] [Related]
8. Low-dimensional compounds containing bioactive ligands. Part XIV: High selective antiproliferative activity of tris(5-chloro-8-quinolinolato)gallium(III) complex against human cancer cell lines.
Litecká M; Hreusová M; Kašpárková J; Gyepes R; Smolková R; Obuch J; David T; Potočňák I
Bioorg Med Chem Lett; 2020 Jul; 30(13):127206. PubMed ID: 32354569
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dibromo-8-quinolinolato-lanthanides.
Liu YC; Chen ZF; Song XY; Peng Y; Qin QP; Liang H
Eur J Med Chem; 2013 Jan; 59():168-75. PubMed ID: 23220645
[TBL] [Abstract][Full Text] [Related]
10. Platinum(II) complexes containing aminophosphonate esters: Synthesis, characterization, cytotoxicity and action mechanism.
Huang KB; Chen ZF; Liu YC; Li ZQ; Wei JH; Wang M; Xie XL; Liang H
Eur J Med Chem; 2013 Jun; 64():554-61. PubMed ID: 23685573
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Structure Characterization and Antitumor Activity Study of a New Iron(III) Complex of 5-Nitro-8-hydroxylquinoline (HNOQ).
Zhang HR; Meng T; Liu YC; Qin QP; Chen ZF; Liu YN; Liang H
Chem Pharm Bull (Tokyo); 2016 Aug; 64(8):1208-17. PubMed ID: 27238362
[TBL] [Abstract][Full Text] [Related]
12. High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Eur J Med Chem; 2019 May; 169():103-110. PubMed ID: 30870791
[TBL] [Abstract][Full Text] [Related]
13. Low-dimensional compounds containing bioactive ligands. V: Synthesis and characterization of novel anticancer Pd(II) ionic compounds with quinolin-8-ol halogen derivatives.
Vranec P; Potočňák I; Sabolová D; Farkasová V; Ipóthová Z; Pisarčíková J; Paulíková H
J Inorg Biochem; 2014 Feb; 131():37-46. PubMed ID: 24239911
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-localizing dicarbohydrazide Ln complexes and their mechanism of in vitro anticancer activity.
Meng T; Liu T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Dalton Trans; 2020 Apr; 49(14):4404-4415. PubMed ID: 32175553
[TBL] [Abstract][Full Text] [Related]
15. A Ce(iii) complex potently inhibits the activity and expression of tyrosine phosphatase SHP-2.
Lin L; Lu L; Du R; Yuan C; Zhu M; Fu X; Xing S
Dalton Trans; 2019 Dec; 48(47):17673-17682. PubMed ID: 31763642
[TBL] [Abstract][Full Text] [Related]
16. Copper(II/I) complexes of 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline: synthesis, crystal structure, antitumor activity and DNA interaction.
Huang KB; Chen ZF; Liu YC; Wang M; Wei JH; Xie XL; Zhang JL; Hu K; Liang H
Eur J Med Chem; 2013; 70():640-8. PubMed ID: 24211640
[TBL] [Abstract][Full Text] [Related]
17. Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis.
Qin QP; Chen ZF; Qin JL; He XJ; Li YL; Liu YC; Huang KB; Liang H
Eur J Med Chem; 2015 Mar; 92():302-13. PubMed ID: 25575314
[TBL] [Abstract][Full Text] [Related]
18. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, hydrolytic DNA-cleaving activities and cytotoxicities of EDTA analogue-tethered pyrrole-polyamide dimer-based Ce(IV) complexes.
Yang JW; Lin YL; Dong C; Zhou CQ; Chen JX; Wang B; Zhou ZZ; Sun B; Chen WH
Eur J Med Chem; 2014 Nov; 87():168-74. PubMed ID: 25247773
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.
Tang Q; Ni WX; Leung CF; Man WL; Lau KK; Liang Y; Lam YW; Wong WY; Peng SM; Liu GJ; Lau TC
Chem Commun (Camb); 2013 Nov; 49(85):9980-2. PubMed ID: 24042270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
